Al-Mansour Pharmaceuticals Industries submitted its financial statements for the third quarter of 2026 to the Authority, in compliance with ISX financial disclosure requirements.

Al-Mansour Pharmaceuticals Industries submitted its financial statements for the third quarter of 2026 to the Authority, in compliance with ISX financial disclosure requirements.